Director / Senior Director Clinical Imaging Research Scientist at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

PhD or MD with a specialization in Medical Imaging, Biomedical Engineering, Computational Biology or other image analysis related discipline
Minimum of 5 years of professional experience in clinical imaging applications
Evidence of direct role and contribution to medical image analysis in targeted radionuclide therapy studies (publications in peer-reviewed scientific journals, presentations at conferences and/or developed software codes)
Knowledge of both physiological and instrumental factors that may affect quantitative accuracy of clinical imaging procedures in oncology, especially in targeted radionuclide therapies
Strong technical understanding of SPECT, PET, CT, and MR image acquisition, reconstruction, processing, quantitative analyses, and interpretations for therapeutic applications
Participation in clinical trials

Responsibilities

Provide strategic and technical input on the development, implementation and evaluation of imaging biomarkers and image analysis techniques in various phases of clinical development across therapeutic areas such as Oncology, Diabetes, Immunology, and Neurodegeneration
Analyze molecular imaging data obtained within targeted radionuclide therapy studies to locate tumors, assess tracer biodistribution for personalized dosimetry and treatment planning, and evaluate treatment efficacy through follow-up imaging
Design and implement customized imaging programs in clinical trials and image analysis methods, leveraging novel and standard methodologies
Lead cross-functional projects with internal research and clinical (medical, operations, statistics, regulatory) teams
Develop and maintain productive external partnerships (Contract Research Organizations, software developers, scanner manufacturers, academic institutions) to support the validation of clinical imaging instrumentation and its application in therapeutic development
Evaluate key scientific developments in clinical image analysis and implement emerging technologies including modeling and artificial intelligence
Develop, validate, and implement image analysis methodologies and software tools for quantitative clinical image analyses as well as analyze clinical images from various modalities, such as PET, SPECT, CT, and MRI
Author and review clinical trial documents (protocols, study reports, and technical manuals)
Communicate, present, and publish conference abstracts and manuscripts

Skills

Image Analysis

Quantitative Imaging

Imaging Biomarkers

Molecular Imaging

Personalized Dosimetry

Theranostics

Nuclear Medicine

Oncology Imaging

Diabetes Imaging

Immunology Imaging

Neurodegeneration Imaging

Tracer Biodistribution

Treatment Planning

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free